Table 1.
Demographic and Clinical Characteristics of Enrolled Patients
| Characteristic | Total (n=322) | UC (n=174) | CD (n=148) |
|---|---|---|---|
| Age, yr | 39.7±14.2 | 45.2±14.0 | 33.2±11.6 |
| Male sex | 218 (67.7) | 100 (57.5) | 118 (79.7) |
| Current or prior use of medications | |||
| Steroids | 203 (63.0) | 105 (60.3) | 98 (66.2) |
| Immunosuppressant | 191 (59.3) | 103 (59.2) | 120 (81.1) |
| Biologics | 113 (35.1) | 39 (22.4) | 74 (50.0) |
| Prior surgery for IBD | 67 (20.8) | 8 (4.6) | 59 (39.9) |
| Hospitalization episodes | 207 (64.3) | 85 (48.9) | 122 (82.4) |
| Disease activity (point) | |||
| Crohn’s Disease Activity Index | - | - | 63.3±66.0 |
| Partial Mayo score | - | 0.8±1.3 | - |
| Disease extent of UC | |||
| Proctitis | - | 53 (30.5) | - |
| Left-sided colitis | - | 71 (40.8) | - |
| Extensive colitis | - | 50 (28.7) | - |
| Disease location of CD | |||
| L1 (ileum) | - | - | 27 (18.2) |
| L2 (colon) | - | - | 15 (10.1) |
| L3 (ileum+colon) | - | - | 105 (70.9) |
| L4 (upper gastrointestinal tract) | - | - | 1 (0.7) |
| Disease behavior of CD | |||
| Inflammation | - | - | 52 (35.1) |
| Stricture | - | - | 57 (38.5) |
| Penetration | - | - | 39 (26.4) |
Data are presented as mean±SD or number (%).
UC, ulcerative colitis; IBD, inflammatory bowel disease; CD, Crohn’s disease.